杭州澳亚生物技术股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
20
NMPA:20
Drug Approvals
Thymopentin for Injection
- Product Name
- 注射用胸腺五肽
- Approval Number
- 国药准字H20093331
- Approval Date
- Aug 6, 2023
NMPA
Carbazochrome Sodium Sulfonate for Injection
- Product Name
- 注射用卡络磺钠
- Approval Number
- 国药准字H20084042
- Approval Date
- Mar 14, 2023
NMPA
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20066137
- Approval Date
- Jun 23, 2020
NMPA
Cytidine Disodium Triphosphate for Injection
- Product Name
- 注射用三磷酸胞苷二钠
- Approval Number
- 国药准字H20067889
- Approval Date
- May 22, 2020
NMPA
Adenosine Cyclophosphate for Injection
- Product Name
- 注射用环磷腺苷
- Approval Number
- 国药准字H20056686
- Approval Date
- May 22, 2020
NMPA
Alprostadil for Injection
- Product Name
- 注射用前列地尔
- Approval Number
- 国药准字H33022151
- Approval Date
- May 22, 2020
NMPA
Ganciclovir for Injection
- Product Name
- 注射用更昔洛韦
- Approval Number
- 国药准字H20055911
- Approval Date
- May 22, 2020
NMPA
Ribonucleic Acid Ⅲ for Injection
- Product Name
- 注射用核糖核酸Ⅲ
- Approval Number
- 国药准字H20003228
- Approval Date
- May 22, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found